90 related articles for article (PubMed ID: 10051997)
21. [Epidemiology, natural history and pathogenesis of hepatocellular carcinoma].
Merle P
Cancer Radiother; 2005 Nov; 9(6-7):452-7. PubMed ID: 16226912
[TBL] [Abstract][Full Text] [Related]
22. [The influence of HCV core protein and apoptosis on cellular telomerase activities].
Quan J; Fan XG; Hu GL; Li N; Tan DM
Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):424. PubMed ID: 15268809
[No Abstract] [Full Text] [Related]
23. [Relationship between chronic viral hepatitis and hepatocellular carcinoma].
Karev VE; Tsinzerling VA; Komarova DV; Iakovlev AA
Vopr Onkol; 2000; 46(4):427-32. PubMed ID: 11147418
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B virus core variants modify natural course of viral infection and hepatocellular carcinoma progression.
Sung FY; Jung CM; Wu CF; Lin CL; Liu CJ; Liaw YF; Tsai KS; Yu MW
Gastroenterology; 2009 Nov; 137(5):1687-97. PubMed ID: 19664630
[TBL] [Abstract][Full Text] [Related]
25. Re: García-Samaniego et al.--Hepatocellular carcinoma in patients with HCV-HIV coinfection.
Toyoda H; Hayashi K; Nakano I; Fukuda Y
Am J Gastroenterol; 2001 Dec; 96(12):3441-2. PubMed ID: 11774969
[No Abstract] [Full Text] [Related]
26. [Hepatitis B and C viruses in hepatocellular carcinoma in Senegal].
Ka MM; Ndiaye MF; Herve P; Legueno B; Diop BM; Dangou JM; Niang A; Woto-Gaye G; Mendes V; Diop TM; Ndiaye PD; Bao O
Dakar Med; 1996; Spec No():59-62. PubMed ID: 14520992
[No Abstract] [Full Text] [Related]
27. Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus-an analysis of 236 consecutive patients with a single lesion.
Koike Y; Shiratori Y; Sato S; Obi S; Teratani T; Imamura M; Hamamura K; Imai Y; Yoshida H; Shiina S; Omata M
Hepatology; 2000 Dec; 32(6):1216-23. PubMed ID: 11093727
[TBL] [Abstract][Full Text] [Related]
28. Interleukin 1beta gene polymorphism and hepatitis C virus-related hepatocellular carcinoma.
Yeo AE; Tanaka Y; Furuta T
Hepatology; 2003 Jul; 38(1):267-8; author reply 268-9. PubMed ID: 12830011
[No Abstract] [Full Text] [Related]
29. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
[TBL] [Abstract][Full Text] [Related]
30. Conditional hepatocarcinogenesis in mice expressing SV 40 early sequences.
Lou DQ; Molina T; Bennoun M; Porteu A; Briand P; Joulin V; Vasseur-Cognet M; Cavard C
Cancer Lett; 2005 Nov; 229(1):107-14. PubMed ID: 16157222
[TBL] [Abstract][Full Text] [Related]
31. Virological analysis, genotypes and mutational patterns of the HBV precore/core gene in HBV/HCV-related hepatocellular carcinoma.
De Mitri MS; Cassini R; Morsica G; Bagaglio S; Andreone P; Loggi E; Muratori P; Bernardi M
J Viral Hepat; 2006 Sep; 13(9):574-81. PubMed ID: 16907843
[TBL] [Abstract][Full Text] [Related]
32. [Steatosis and hepatitis C].
Testino G
Recenti Prog Med; 2005 Dec; 96(12):621-33; quiz 654. PubMed ID: 16496750
[TBL] [Abstract][Full Text] [Related]
33. Analysis of intrahepatic lymphocyte subsets in a transgenic mouse model of immune-mediated hepatocarcinogenesis.
Nakamoto Y; Kaneko S
J Exp Clin Cancer Res; 2006 Mar; 25(1):55-7. PubMed ID: 16761618
[TBL] [Abstract][Full Text] [Related]
34. Hepatocellular carcinoma: Can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C?
Moya A; Berenguer M; Aguilera V; Juan FS; Nicolás D; Pastor M; López-Andujar R; Rayón M; Orbis F; Mora J; De Juan M; Carrasco D; Vila JJ; Prieto M; Berenguer J; Mir J
Liver Transpl; 2002 Nov; 8(11):1020-7. PubMed ID: 12424715
[TBL] [Abstract][Full Text] [Related]
35. Comparison of limited and anatomic hepatic resection for hepatocellular carcinoma with hepatitis C.
Kaibori M; Matsui Y; Hijikawa T; Uchida Y; Kwon AH; Kamiyama Y
Surgery; 2006 Mar; 139(3):385-94. PubMed ID: 16546504
[TBL] [Abstract][Full Text] [Related]
36. Core promoter mutations of hepatitis B virus and hepatocellular carcinoma: story beyond A1762T/G1764A mutations.
Liu CJ; Kao JH
J Gastroenterol Hepatol; 2008 Mar; 23(3):347-50. PubMed ID: 18318819
[No Abstract] [Full Text] [Related]
37. [Comparison of hepatitis B virus and hepatitis C virus seroprevalence in hepatocellular carcinoma].
Sarr A; Sow AM; Diallo A; Mendez V; Ka Cisse M
Dakar Med; 1996; Spec No():21-3. PubMed ID: 14520981
[No Abstract] [Full Text] [Related]
38. [Hepatitis virus and hepatocellular carcinoma].
Rosmorduc O; Paterlini P; Poupon R; Brechot C
Gastroenterol Clin Biol; 1999 Mar; 23(3):363-75. PubMed ID: 10384341
[No Abstract] [Full Text] [Related]
39. Interferon: benefit beyond hepatitis therapy?
Mallat DB; El-Serag HB
Am J Gastroenterol; 2001 Dec; 96(12):3435-6. PubMed ID: 11774964
[No Abstract] [Full Text] [Related]
40. [Hepatitis viruses and hepatocarcinogenesis].
Kiss A; Lotz G; Kaposi NP; Schaff Z
Orv Hetil; 2002 Jan; 143(2):83-6. PubMed ID: 11868453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
